RYZB insider filings

RayzeBio, Inc. — 23 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-02-28. Screen RYZB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for RYZB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — RayzeBio, Inc.

FiledFormInsiderReported transactionsSource
2024-02-284VIKING GLOBAL INVESTORS LP — 10% owner
Viking Global Opportunities Parent GP LLC — 10% owner
Viking Global Opportunities Drawdown GP LLC — 10% owner
Viking Global Opportunities Drawdown Portfolio GP LLC — 10% owner
Viking Global Opportunities Drawdown (Aggregator) LP — 10% owner
HALVORSEN OLE ANDREAS — 10% owner
Ott David C. — 10% owner
Shabet Rose Sharon — 10% owner
Other (J): 4,899,144 · Other (J): 1,743,556EDGAR
2024-02-284VIKING GLOBAL INVESTORS LP — 10% owner
Viking Global Opportunities Parent GP LLC — 10% owner
Viking Global Opportunities GP LLC — 10% owner
Viking Global Opportunities Portfolio GP LLC — 10% owner
Viking Global Opportunities Illiquid Investments Sub-Master LP — 10% owner
HALVORSEN OLE ANDREAS — 10% owner
Ott David C. — 10% owner
Shabet Rose Sharon — 10% owner
Other (J): 4,899,144 · Other (J): 1,743,556EDGAR
2024-02-274Moran Susan — CHIEF MEDICAL OFFICERDisposition to issuer (D): 323,455 @ $62.50 · Disposition to issuer (D): 60,757 (derivative) · Disposition to issuer (D): 77,805 (derivative) · Disposition to issuer (D): 194,514 (derivative) · Disposition to issuer (D): 164,000 (derivative)EDGAR
2024-02-274Kush Arvind — CHIEF FINANCIAL OFFICERDisposition to issuer (D): 78,433 @ $62.50 · Disposition to issuer (D): 301,745 (derivative) · Disposition to issuer (D): 149,777 (derivative) · Disposition to issuer (D): 164,000 (derivative)EDGAR
2024-02-274Oliger Christy J. — DirectorDisposition to issuer (D): 114,579 (derivative)EDGAR
2024-02-274Van Hauwermeiren Timothy — DirectorDisposition to issuer (D): 48,628 (derivative)EDGAR
2024-02-274Larson Yi — DirectorDisposition to issuer (D): 59,399 (derivative) · Disposition to issuer (D): 14,332 (derivative) · Disposition to issuer (D): 40,848 (derivative)EDGAR
2024-02-274Katabi Maha — DirectorDisposition to issuer (D): 1,209,764 @ $62.50 · Disposition to issuer (D): 1,209,764 @ $62.50 · Disposition to issuer (D): 18,235 (derivative)EDGAR
2024-02-274You Angie — DirectorDisposition to issuer (D): 73,731 (derivative) · Disposition to issuer (D): 40,848 (derivative)EDGAR
2024-02-274SONG KENNETH — PRESIDENT AND CHIEF EXECUTIVE, DirectorDisposition to issuer (D): 1,622,968 @ $62.50 · Disposition to issuer (D): 758,607 (derivative) · Disposition to issuer (D): 114,763 (derivative) · Disposition to issuer (D): 480,000 (derivative)EDGAR
2024-02-274Heyman Richard A. — DirectorDisposition to issuer (D): 367,446 @ $62.50EDGAR
2024-02-274TAGLIAFERRI MARY — DirectorDisposition to issuer (D): 73,731 (derivative) · Disposition to issuer (D): 40,848 (derivative)EDGAR
2024-02-064Moran Susan — CHIEF MEDICAL OFFICEROption exercise (M): 30,875 @ $3.24 · Option exercise (M): 30,875 (derivative) @ $0EDGAR
2023-11-174Kush Arvind — Chief Financial OfficerGrant/award (A): 164,000 (derivative) @ $0EDGAR
2023-11-174Moran Susan — Chief Medical OfficerGrant/award (A): 164,000 (derivative) @ $0EDGAR
2023-11-174Katabi Maha — DirectorGrant/award (A): 18,235 (derivative) @ $0EDGAR
2023-11-174SONG KENNETH — President and Chief Executive, DirectorGrant/award (A): 480,000 (derivative) @ $0EDGAR
2023-09-214Katabi Maha — DirectorConversion (C): 973,653 · Conversion (C): 973,653 · Purchase (P): 236,111 @ $18 · Purchase (P): 236,111 @ $18 · Conversion (C): 973,653 (derivative) · Conversion (C): 973,653 (derivative)EDGAR
2023-09-214Redmile Group, LLC — 10% owner
Green Jeremy — 10% owner
Redmile Biopharma Investments II, L.P. — 10% owner
Conversion (C): 864,509 · Conversion (C): 494,687 · Conversion (C): 498,510 · Conversion (C): 864,509 (derivative) @ $0 · Conversion (C): 432,254 (derivative) @ $0 · Conversion (C): 498,510 (derivative) @ $0EDGAR
2023-09-214venBio Global Strategic Fund III, L.P. — 10% owner
VENBIO GLOBAL STRATEGIC GP III, L.P. — 10% owner
VENBIO GLOBAL STRATEGIC GP III, LTD — 10% owner
Adelman Robert J — 10% owner
GOODMAN COREY S — 10% owner
Conversion (C): 3,786,957 · Conversion (C): 1,123,862 · Conversion (C): 247,343 · Conversion (C): 3,786,957 (derivative) · Conversion (C): 1,123,862 (derivative) · Conversion (C): 216,127 (derivative)EDGAR
2023-09-214VIKING GLOBAL INVESTORS LP — 10% owner
Viking Global Opportunities Parent GP LLC — 10% owner
Viking Global Opportunities Drawdown GP LLC — 10% owner
Viking Global Opportunities Drawdown Portfolio GP LLC — 10% owner
Viking Global Opportunities Drawdown (Aggregator) LP — 10% owner
HALVORSEN OLE ANDREAS — 10% owner
Ott David C. — 10% owner
Shabet Rose Sharon — 10% owner
Conversion (C): 864,509 · Conversion (C): 494,687 · Conversion (C): 2,609,392 · Purchase (P): 930,556 @ $18 · Conversion (C): 1,285,223 · Purchase (P): 458,333 @ $18 · +4 moreEDGAR
2023-09-214VIKING GLOBAL INVESTORS LP — 10% owner
Viking Global Opportunities Parent GP LLC — 10% owner
Viking Global Opportunities GP LLC — 10% owner
Viking Global Opportunities Portfolio GP LLC — 10% owner
Viking Global Opportunities Illiquid Investments Sub-Master LP — 10% owner
HALVORSEN OLE ANDREAS — 10% owner
Ott David C. — 10% owner
Shabet Rose Sharon — 10% owner
Conversion (C): 864,509 · Conversion (C): 494,687 · Conversion (C): 2,609,392 · Purchase (P): 930,556 @ $18 · Conversion (C): 1,285,223 · Purchase (P): 458,333 @ $18 · +4 moreEDGAR
2023-09-194Wellington Biomedical Innovation Master Investors (Cayman) II L.P. — 10% ownerConversion (C): 1,557,846 · Conversion (C): 1,557,846 (derivative) @ $0EDGAR

Recent 8-K events — RayzeBio, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-02-268-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-268-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-09-198-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RYZB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs